GP-Act III Acquisition Corp. (GPAT) Earnings History
Profitable6 years of earnings data (2020–2025) · Positive TTM net income
Loading earnings history...
GP-Act III Acquisition Corp. (GPAT) Earnings Overview
As of June 13, 2026, GP-Act III Acquisition Corp. (GPAT) reported trailing twelve-month net income of $12M, reflecting -12.8% year-over-year growth. The company earned $0.41 per diluted share over the past four quarters.
Looking at the long-term picture, GPAT's historical earnings data spans multiple years. The company achieved its highest annual net income of $12M in fiscal 2025, representing a new all-time high.
GP-Act III Acquisition Corp. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PSFE (-$199M net income, -10.7% margin), ACIC ($107M net income, 31.8% margin), GS ($17.18B net income, 13.7% margin), GPAT has comparable earnings metrics. Compare GPAT vs PSFE →
GPAT Earnings vs Peers
Earnings metrics vs comparable public companies
GPAT Historical Earnings Data (2020–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $12M | +37.1% | $-551,918 | $0.41 | - | - |
| 2024 | $9M | +61862.0% | $-565,000 | $0.47 | - | - |
| 2023 | $-14,041 | +54.5% | $-14,041 | $-0.00 | - | - |
| 2022 | $-30,844 | -676.3% | $-30,840 | $-0.00 | - | - |
| 2020 | $-3,973 | - | $-3,970 | $-0.00 | - | - |
Download Data
Export GPAT earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in GPAT back in 2020?
Total return with dividends reinvested · 6+ years of data
Calculate ReturnsHow much would $100/month in GPAT be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs GPAT Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationGPAT vs BRK-B — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Berkshire Hathaway Inc..
Compare NowGPAT — Frequently Asked Questions
Quick answers to the most common questions about buying GPAT stock.
What is GPAT earnings per share (EPS)?
GPAT trailing twelve-month (TTM) diluted EPS is $0.41, reflecting -12.8% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is GP-Act III Acquisition Corp.'s net income?
GP-Act III Acquisition Corp. (GPAT) trailing twelve-month net income is $12M as of 2025. Earnings declined -12.8% year-over-year. GP-Act III Acquisition Corp. has been profitable for 2 consecutive years.
Is GPAT profitable?
Yes, GPAT is profitable with a TTM net income of $12M and a net profit margin of N/A. GP-Act III Acquisition Corp. has generated profits for 2 consecutive years.
What is GPAT's earnings growth rate?
GPAT compound annual EPS growth rates (CAGR): 1-Year: -12.8%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are GPAT's profit margins?
GP-Act III Acquisition Corp. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.1%.
Is GPAT growing earnings?
GPAT earnings are declining — EPS fell -12.8% year-over-year. TTM net income dropped to $12M. This contrasts with the 5-year CAGR of N/A.
What was GPAT's best earnings year?
GP-Act III Acquisition Corp.'s highest annual net income on record is $12M, achieved in fiscal year 2025. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were GPAT's earnings last quarter?
GPAT's most recent reported quarter was Q4 2025. Net income was $3M with diluted EPS of $0.08. For a full breakdown of all quarters, see the quarterly earnings table on this page.